Clareo Health | An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects
An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medical University of Vienna
Age
50–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Men and women aged over 50 years
Ametropia of less than 6 diopters and anisometropia of less than 2 diopters
Clear non-lenticular ocular media
AMD patients:
Patients with nonexudative AMD
Visual acuity in the study eye \> 20/60
Glaucoma patients:
Unilateral or bilateral primary open angle glaucoma
At least 3 reliable visual field testings
Treated intraocular pressure \< 21 mmHg,
Visual field mean deviation MD \<10 (Humphrey 30-2)
Healthy control subjects:
Age- , gender- and sex- matched to the two patient groups,
Matched with regard to smoking habits of the two patient group
No observable eye diseases
You may not be if
History or presence of gastrointestinal, liver or kidney disease, or other conditions known to interfere with distribution, metabolism or excretion of the study drug
Blood donation during the previous 3 weeks
Abuse of alcoholic beverages or drugs, participation in a clinical trial in the 3 weeks preceding the study
Known diabetes mellitus
Presence of any ocular pathology that interferes with the aims of the present study
Intraocular surgery within the last 3 weeks
Hypersensitivity to moxaverine
Acute gastric bleeding, massive cerebral hemorrhage related to stroke
